The Netherlands Cancer Institute is a comprehensive cancer center in which clinical research is the crucial link between basic and translational research, and patient impact. Approximately 25% of our patients are enrolled in clinical trials. The majority of these trials are investigator-initiated, and we collaborate with numerous centers across the globe.
Our institute specializes in innovative Phase I/II trials that are often run in collaboration with our basic and translational research groups. Over the years, we have built up a large repository of patient data and a large collection of tumor tissue and healthy tissue.